Â
The UK government has announced plans to establish a dedicated artificial intelligence research organisation aimed at strengthening the country’s defences against biological threats,
combining advanced AI technology with scientific expertise to improve disease surveillance and accelerate the development of medical treatments.
The AI Biosecurity Lab (AIBL) will receive £100 million in government funding, alongside up to £200 million in commitments from leading AI companies OpenAI and Anthropic. The initiative forms part of the government’s wider National AI Biosecurity Initiative and is intended to position Britain at the forefront of AI-driven biological security.
The announcement, published by the Cabinet Office on 24 October, comes as increasingly sophisticated AI systems offer new opportunities for medical research while raising concerns about their potential misuse. Although AI can help scientists understand diseases and develop treatments more quickly, the same technological advances could also make certain harmful biological activities easier to carry out.
The new laboratory will focus on using AI to strengthen the UK’s ability to identify, prevent and respond to biological risks, supporting the country’s broader Biological Security Strategy.
Early detection and faster medical breakthroughs
AIBL’s initial priorities will centre on two areas: identifying emerging biological threats at an earlier stage and accelerating the discovery, development and testing of vaccines, treatments and other medical countermeasures.
The organisation will bring together specialists in artificial intelligence, life sciences and biosecurity to turn technological advances into practical tools for public health protection. It will collaborate with national biosecurity centres, research institutions and industry partners to improve preparedness for disease outbreaks and other biological emergencies.
By expanding the use of advanced AI in scientific research, the government aims to help authorities recognise potential threats sooner and improve the speed at which effective medical responses can be developed.
The laboratory’s work will address a broad range of biological risks, including those associated with the growing capabilities of AI systems.
OpenAI and Anthropic commit up to £200 million
Two major AI developers will provide the initial technological support for the project, contributing computing resources, access to advanced models and specialist expertise.
OpenAI has committed £100 million in computing resources and model credits, together with trusted access to relevant advanced AI models through its Rosalind Biodefense programme.
Anthropic will contribute up to £100 million in model credits, trusted access to its AI systems and dedicated technical support.
The laboratory will also establish research partnerships with Google DeepMind and Basecamp Research, a UK-based company working at the intersection of artificial intelligence and biology.
Basecamp Research will contribute access to its AI-biology models, technical capabilities and scientific expertise to help address priority biosecurity challenges. Google DeepMind scientists and biosecurity specialists will collaborate with AIBL on research projects, with the potential for trusted access to advanced Gemini systems and specialised scientific models.
The government expects these partnerships to help combine expertise and resources across the technology and life sciences sectors, strengthening the practical application of AI to biological security.
Independent organisation with public-sector links
AIBL will operate as an independent, non-profit organisation, with a structure designed to attract leading researchers and technical specialists from academia and industry.
Its operating model is intended to provide the flexibility and autonomy needed to work at the pace of advanced AI development while maintaining a clear public-interest mission. The government says the organisation will pursue an approach comparable in some respects to the UK’s AI Security Institute.
A scientific advisory committee will provide guidance, drawing on expertise from academia, industry and the third sector. Further details about the committee and its membership are expected to be announced later.
Despite its independence, the laboratory will maintain close relationships with government agencies responsible for biological security, public health and scientific research.
National cooperation on biological security
The initiative will bring together the AI Biosecurity Lab, the life sciences sector and several key public bodies, including the UK Health Security Agency, the Animal and Plant Health Agency and the Defence Science and Technology Laboratory.
AIBL will also work with the Medicines and Healthcare products Regulatory Agency to strengthen preparations for health emergencies and contribute to the development of regulatory approaches for medicines designed with AI.
The government intends to draw on both public and philanthropic funding to support the laboratory’s development and expand investment in biological security over time.
Through the initiative, Britain aims to capture the scientific and medical benefits of advanced AI while reducing the risks associated with its misuse. The success of the project will depend on how effectively its research partnerships translate new AI capabilities into earlier threat detection, stronger emergency preparedness and faster development of life-saving medical interventions. Photo by Jernej Furman from Slovenia, Wikimedia commons.
